Replies to post #294755 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

That bioselect is interesting. Who is that?

Honestly, I have not focused on these two companies at all. But certainly their volatility is quite insane. Those would probably not be companies I’d invest in, but nonetheless, who would not have wanted to have just by chance posted a trigger price order to sell if the stock ever reached $9500 or so.

[sentiment_stocks]

Hmmm... Gritstone is a favorite source for jondoeuk to reference when writing a post with a multiple series of links to various studies for neoantigen vaccines, and how much better they will fare than DCVax.

Here’s one of several from 2019.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149291396

[anders2211]

as a thumb of rule a would like to short all bio techs 3 months after IPO and or with overrated MC, it will create a win 9 out of 10

[CogDiss 1188X]

CLSN from $9500 to $1 a share

This doesn’t pass the smell test. If this chart were correct, then Celsion would have been worth $317 billion back in the day., more than 50% bigger than Merck now.

I suspect this is one of those bad data situations after multiple reverse splits.

In any case, Biosect’s point was that OTC stocks are subject to manipulation and in any case, the market is not efficient.

Your two examples are NASDAQ stocks. Is it your contention that microcap OTC stocks are free from manipulation or that microcap biotech OTC stocks are efficient in terms of information and price?